Cyclic Ruthenium-Peptide Conjugates as Integrin-Targeting Phototherapeutic Prodrugs for the Treatment of Brain Tumors
Journal of the American Chemical Society · 2023
DOI: 10.1021/jacs.3c04855 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2023. Verfasst von Liyan Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Leiden Institute of Chemistry, Universiteit Leiden, Einsteinweg 55, 2333 CC Leiden, Netherlands. Hauptthemen laut MEDLINE: Ruthenium, Prodrugs, Brain Neoplasms, Coordination Complexes. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, China Scholarship Council, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Leiden Institute of Chemistry, Universiteit Leiden, Einsteinweg 55, 2333 CC Leiden, Netherlands.
- State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian 116024, P. R. China.
- Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, P. R. China.
- Leiden Institute of Biology, Universiteit Leiden, Einsteinweg 55, 2333 CC Leiden, Netherlands.
- Leiden Academic Centre for Drug Research, Universiteit Leiden, Einsteinweg 55, 2333 CC Leiden, Netherlands.
- Department of Chemistry and Industrial Chemistry, University of Pisa, 56124 Pisa, Italy.
ORCID-Profile: Peiyuan Wang, Ludovic Bretin, Yurii Husiev, Tarita Biver, Sylvia E Le Dévédec, Wen Sun, Sylvestre Bonnet
Förderung
- European Research Council
- China Scholarship Council
- National Natural Science Foundation of China
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Zhang, L., Wang, P., Zhou, X. Q., Bretin, L., Zeng, X., Husiev, Y., Polanco, E. A., Zhao, G., Wijaya, L. S., Biver, T., Le Dévédec, S. E., Sun, W., & Bonnet, S. (2023). Cyclic Ruthenium-Peptide Conjugates as Integrin-Targeting Phototherapeutic Prodrugs for the Treatment of Brain Tumors. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.3c04855
Vancouver
Zhang L, Wang P, Zhou XQ, Bretin L, Zeng X, Husiev Y, et al. Cyclic Ruthenium-Peptide Conjugates as Integrin-Targeting Phototherapeutic Prodrugs for the Treatment of Brain Tumors. Journal of the American Chemical Society. 2023. doi:10.1021/jacs.3c04855
BibTeX
@article{Zhang2023,
author = {Zhang, Liyan and Wang, Peiyuan and Zhou, Xue-Quan and Bretin, Ludovic and Zeng, Xiaolong and Husiev, Yurii and Polanco, Ehider A and Zhao, Gangyin and Wijaya, Lukas S and Biver, Tarita and Le Dévédec, Sylvia E and Sun, Wen and Bonnet, Sylvestre},
title = {Cyclic Ruthenium-Peptide Conjugates as Integrin-Targeting Phototherapeutic Prodrugs for the Treatment of Brain Tumors},
journal = {Journal of the American Chemical Society},
year = {2023},
doi = {10.1021/jacs.3c04855}
}
EUVIMED